Altria: UBS downgrades to Sell from Neutral, adjusts Price Target to $38 from $43

GSK: UBS cut its recommendation to sell from neutral. PT down 4.4% to 1,300 pence.

Intel: J.P. Morgan downgrades to underweight from rating suspended. PT up 7.5% to $32.

M&G: Jefferies initiated coverage with a recommendation of buy. PT set to 235 pence.

Roku: Jefferies initiated coverage with a recommendation of hold. PT set to $45.